Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maddocks

Showing results (31-40 of 215) with videos related to

Pageof 22
Sort By:
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Blood Advances|January 18, 2019
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapyDaniel J Landsburg, Mitchell E Hughes, Alexa Koike, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
Blood|August 17, 2018
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemiaKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Leukemia & Lymphoma|February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphomaFarrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
Cochlear Implants International|December 25, 2016
United Kingdom national paediatric bilateral project: Demographics and results of localization and speech perception testingH E Cullington, D Bele, J C Brinton, et al.
Leukemia|April 6, 2021
Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patientsCecelia R Miller, Ying Huang, Amy S Ruppert, et al.
Cochlear Implants International|January 19, 2017
United Kingdom national paediatric bilateral project: Results of professional rating scales and parent questionnairesH E Cullington, D Bele, J C Brinton, et al.
Cancer|March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalJonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Pageof 22

Showing results (31-40 of 215) with videos related to

Sort By:
Pageof 22
Oncotarget|April 24, 2016
Hsp90 inhibition increases SOCS3 transcript and regulates migration and cell death in chronic lymphocytic leukemiaTimothy L Chen, Nikhil Gupta, Amy Lehman, et al.
Blood Advances|January 18, 2019
Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapyDaniel J Landsburg, Mitchell E Hughes, Alexa Koike, et al.
Leukemia|July 25, 2020
Second cancer incidence in CLL patients receiving BTK inhibitorsDavid A Bond, Ying Huang, James L Fisher, et al.
Leukemia|January 22, 2014
The CD37-targeted antibody-drug conjugate IMGN529 is highly active against human CLL and in a novel CD37 transgenic murine leukemia modelK A Beckwith, F W Frissora, M R Stefanovski, et al.
Blood|August 17, 2018
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemiaKerry A Rogers, Ying Huang, Amy S Ruppert, et al.
Leukemia & Lymphoma|February 12, 2015
Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphomaFarrukh T Awan, Joseph M Flynn, Jeffrey A Jones, et al.
Cochlear Implants International|December 25, 2016
United Kingdom national paediatric bilateral project: Demographics and results of localization and speech perception testingH E Cullington, D Bele, J C Brinton, et al.
Leukemia|April 6, 2021
Significance of chromosome 2p gain in ibrutinib-treated chronic lymphocytic leukemia patientsCecelia R Miller, Ying Huang, Amy S Ruppert, et al.
Cochlear Implants International|January 19, 2017
United Kingdom national paediatric bilateral project: Results of professional rating scales and parent questionnairesH E Cullington, D Bele, J C Brinton, et al.
Cancer|March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survivalJonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Pageof 22